Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Millions | 3 Months Ended | 9 Months Ended |
Sep. 30, 2017 | Sep. 30, 2016 | Sep. 30, 2017 | Sep. 30, 2016 |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 43.5 | $ 37.6 | $ 101.5 | $ 97.1 |
Stock-based compensation expense related to stock options, SAR and ESPP grants | | $ 20.9 | $ 18.8 | $ 42.9 | $ 45 |
Common Shares Available for Grant | | 17,100,000 | | 17,100,000 | |
Unrecognized compensation expense | | $ 110.3 | | $ 110.3 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 8 months 12 days | |
Stock Options and SARs [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 23.94 | $ 25.77 |
Expected Volatility (in hundredths) | | | | 28.28% | 31.52% |
Risk-Free Interest Rate (in hundredths) | | | | 1.52% | 0.78% |
Dividend Yield (in hundredths) | | | | 0.75% | 0.76% |
Expected Life (in years) | | | | 5 years 1 month 6 days | 5 years 4 months 24 days |
Stock Options and SARs Rollforward [Abstract] | | | | | |
Outstanding at January 1 (in shares) | | | | 9,850,000 | 10,744,000 |
Granted (in shares) | | | | 2,260,000 | 1,821,000 |
Exercised (1) (in shares) | [1] | | | (1,674,000) | (1,673,000) |
Forfeited (in shares) | | | | (269,000) | (241,000) |
Outstanding at September 30 (2) (in shares) | [2] | 10,167,000 | 10,651,000 | 10,167,000 | 10,651,000 |
Stock Options and SARs Vested or Expected to Vest (in shares) | [3] | 9,799,000 | 10,300,000 | 9,799,000 | 10,300,000 |
Stock Options and SARs Exercisable at September 30 (in shares) | [4] | 5,517,000 | 6,302,000 | 5,517,000 | 6,302,000 |
Intrinsic Value of Stock Options/SARs Exercised | | | | $ 66.6 | $ 58.7 |
Intrinsic Value of Stock Options/SARs Outstanding | | $ 147.8 | $ 240.8 | $ 147.8 | $ 240.8 |
Weighted Average Remaining Contractual Life for Stock Options/SARs Outstanding | | | | 4 years 3 months 18 days | 4 years 1 month 6 days |
Intrinsic Value of Stock Options/SARs Vested or Expected to Vest | | 145.9 | 237.2 | $ 145.9 | $ 237.2 |
Weighted average remaining contractual life for stock options/SARs vested or expected to vest (in years)al Term | | | | 4 years 3 months 18 days | 4 years |
Aggregate Intrinsic Value for Exercisable Units | | $ 123.2 | $ 196.3 | $ 123.2 | $ 196.3 |
Weighted average remaining contractual life for exercisable options/SARs (in years) | | | | 2 years 9 months 18 days | 2 years 9 months 18 days |
Weighted Average Grant Price Stock Option and SARs [Rollforward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 75.53 | $ 67.98 |
Granted (price per share) | | | | 96.24 | 94.87 |
Exercised (1) (price per share) | [1] | | | 55.63 | 49.85 |
Forfeited (price per share) | | | | 90.22 | 85.77 |
Outstanding at September 30 (2) (price per share) | [2] | $ 83.02 | $ 75.02 | 83.02 | 75.02 |
Vested or Expected to Vest (3) (price per share) | [3] | 82.69 | 74.60 | 82.69 | 74.60 |
Exercisable at September 30 (4) (price per share) | [4] | $ 75.59 | $ 66.46 | 75.59 | 66.46 |
ESPP [Member] | | | | | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 22.10 | $ 19.28 |
Expected Volatility (in hundredths) | | | | 26.96% | 36.54% |
Risk-Free Interest Rate (in hundredths) | | | | 0.89% | 0.43% |
Dividend Yield (in hundredths) | | | | 0.71% | 0.82% |
Expected Life (in years) | | | | 6 months | 6 months |
Restricted Stock And Restricted Stock Units [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Unrecognized compensation expense | | $ 191.2 | | $ 191.2 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 7 months 6 days | |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | |
Share-Based Compensation Arrangement By Restricted Stock And Restricted Stock Units Compensation Cost | | $ 15.8 | $ 13.1 | $ 50 | $ 45.5 |
Outstanding at January 1 (in shares) | | | | 3,962,000 | 4,908,000 |
Granted (in shares) | | | | 1,061,000 | 833,000 |
Released (1) (in shares) | [5] | | | (837,000) | (1,392,000) |
Forfeited (in shares) | | | | (190,000) | (269,000) |
Outstanding at September 30 (2) (in shares) | [6] | 3,996,000 | 4,080,000 | 3,996,000 | 4,080,000 |
Weighted Average Grant Price Restricted Stock and Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (price per share) | | | | $ 79.63 | $ 70.35 |
Granted (price per share) | | | | 97.26 | 87.76 |
Released (1) (price per share) | [5] | | | 59.67 | 53.15 |
Forfeited (price per share) | | | | 84.66 | 76.40 |
Outstanding at September 30 (2) (price per share) | [6] | $ 88.25 | $ 79.37 | $ 88.25 | $ 79.37 |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | |
Intrinsic value released during the year | | | | $ 81.6 | $ 116.3 |
Aggregate intrinsic value of stock and units outstanding | | $ 386.6 | $ 394.6 | 386.6 | 394.6 |
Performance Units and Performance Stock [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 6.8 | 5.7 | 8.6 | $ 6.6 |
Unrecognized compensation expense | | $ 9.4 | | $ 9.4 | |
Weighted average period over which unrecognized compensation expense will be recognized (in years) | | | | 2 years 3 months 18 days | |
Weighted Average Fair Values And Valuation Assumptions Used To Value Stock Option/SARs, ESPP, and Performance Units/Stock Stock-Based Compensation [Abstract] | | | | | |
Weighted Average Fair Value of Grants (price per share) | | | | $ 113.81 | $ 112.09 |
Expected Volatility (in hundredths) | | | | 32.19% | 32.01% |
Risk-Free Interest Rate (in hundredths) | | | | 1.60% | 0.89% |
Restricted Stock/Restricted Stock Units [Roll Forward] | | | | | |
Outstanding at January 1 (in shares) | | | | 545,290 | |
Granted (in shares) | | | | 78,527 | |
Released (1) (in shares) | [5] | | | 240,320 | |
Outstanding at September 30 (2) (in shares) | | 502,331 | | 502,331 | |
Performance Units and Performance Stock Disclosures [Abstract] | | | | | |
Performance Period for Performance Units and Shares | | | | 3 years | |
Additional Performance Awards Granted | | | | 118,834 | |
Minimum Performance Multiple at the Completion of the Performance Period | | | | 0.00% | |
Maximum Performance Multiple at the Completion of the Performance Period | | | | 200.00% | |
Maximum Performance Units and Stock Allowed to be Outstanding | | | | 856,218 | |
Minimum Performance Units and Stock Allowed to be Outstanding | | | | 148,444 | |
Intrinsic value released during the year | | | | $ 23.6 | |
Aggregate intrinsic value of stock and units outstanding | | $ 48.6 | | $ 48.6 | |
Term Of Zero- Coupon Risk- Free Interest Rate In Years Derived From Treasury Constant Maturities Yield Curve | | | | 3 years 3 months 7 days | |
Lease And Well [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 9.5 | 8.9 | $ 30 | $ 28.2 |
Gathering And Processing Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 0.1 | 0.4 | 0.5 | 1 |
Exploration Costs [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | 4.7 | 4.1 | 16.1 | 15.6 |
General And Administrative [Member] | | | | | |
Stock Options/SARs and Employee Stock Purchase Plan (ESPP) Disclosures [Line Items] | | | | | |
Compensation expense related to the company's stock-based compensation plans | | $ 29.2 | $ 24.2 | $ 54.9 | $ 52.3 |
| |
[1] | The total intrinsic value of stock options/SARs exercised for the nine months ended September 30, 2017 and 2016 was $66.6 million and $58.7 million, respectively. The intrinsic value is based upon the difference between the market price of EOG's common stock on the date of exercise and the grant price of the stock options/SARs. | |
[2] | The total intrinsic value of stock options/SARs outstanding at September 30, 2017 and 2016 was $147.8 million and $240.8 million, respectively. At September 30, 2017 and 2016, the weighted average remaining contractual life was 4.3 years and 4.1 years, respectively. | |
[3] | The total intrinsic value of stock options/SARs vested or expected to vest at September 30, 2017 and 2016 was $145.9 million and $237.2 million, respectively. At September 30, 2017 and 2016, the weighted average remaining contractual life was 4.3 years and 4.0 years, respectively. | |
[4] | The total intrinsic value of stock options/SARs exercisable at September 30, 2017 and 2016 was $123.2 million and $196.3 million, respectively. At September 30, 2017 and 2016, the weighted average remaining contractual life was 2.8 years and 2.8 years, respectively. | |
[5] | The total intrinsic value of restricted stock and restricted stock units released for the nine months ended September 30, 2017 and 2016 was $81.6 million and $116.3 million, respectively. The intrinsic value is based upon the closing price of EOG's common stock on the date the restricted stock and restricted stock units are released. | |
[6] | The total intrinsic value of restricted stock and restricted stock units outstanding at September 30, 2017 and 2016 was $386.6 million and $394.6 million, respectively. | |